Yuanhua eyes Hong Kong for assembly plant, IPO in overseas surgical robot push

Shenzhen surgical robot start-up Yuanhua Tech plans to set up an assembly facility in Hong Kong to grow overseas sales and aims to float shares on the city’s bourse to fund development, according to its founder.

In 2022, the company received approval from China’s National Medical Products Administration to sell self-developed orthopaedic robot systems for total and partial knee and hip joint replacement surgeries, founder and chairwoman Li Aili said in an interview.

She expected that the firm, established in 2018, would receive approval next month to market its artificial disc replacement and trauma joint replacement surgery robots.

Having sold some approved systems to hospitals on the Chinese mainland and in Hong Kong, Yuanhua Tech wants to expand to overseas markets, especially Southeast Asia and Europe, with “made in Hong Kong” products, Li said.

“I am looking for suitable manufacturing premises in Tai Po, since our facility at Hong Kong Science and Technology Park in Pak Shek Kok, while good for designing prototypes, is not suitable for large-scale production,” she said.

The company plans to ship components made at its plant in Nanshan, Shenzhen to Hong Kong where robots for overseas clients would be assembled.